期刊文献+

大环内酯类抗生素糖基的结构修饰 被引量:8

Modification on sugars of the macrolide antibiotics
下载PDF
导出
摘要 大环内酯类抗生素是由链霉菌产生的一类弱碱性抗生素及通过其结构修饰得到的衍生物。为发现具有优良抗耐药活性和其他生物活性的化合物、解决当前日益泛滥的细菌耐药性,研究工作者对大环内脂酯类化合物进行了大量的结构修饰。本文在简要介绍大环内酯类抗生素的发展概况的基础上,重点对大环内酯类化合物结构中克拉定糖和去氧氨基糖的结构修饰及对生物活性的影响进行综述。 Macrolide antibiotics produced from Streptomyces and their derivatives obtained by structural modifications are a series of antibacterial agents. In order to overcome the issue of drug resistance and discover novel compounds with remarkable antibacterial activity and other biological effects, numerous semi-synthetic modifications have been conducted on macrolide. In this review, we give an account of the development of macrolide antibiotics, based on which the structural modifications on the cladinose sugar and desosamine sugar of macrolides are highlighted.
作者 郭强 马淑涛
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第1期12-21,58,共11页 Chinese Journal of Antibiotics
关键词 大环内酯类 抗生素类 克拉定糖 去氧氨基糖 结构修饰 Macrolides Antibiotics Cladinose sugar Desosamine sugar Structural modification
  • 相关文献

参考文献7

二级参考文献160

  • 1王登旭,王二兵,彭向前.泰利霉素的药理作用及临床应用[J].中国药物与临床,2005,5(7):524-525. 被引量:7
  • 2马舒冰.红霉素衍生物的半合成及构效关系[J].国外医药(抗生素分册),1996,17(1):33-37. 被引量:5
  • 3尤启冬,魏新,赵英.泰利霉素的合成改进[J].中国医药工业杂志,2007,38(4):318-320. 被引量:9
  • 4葛涵,沈舜义.大环内酯类抗生素研究进展[J].世界临床药物,2007,28(6):376-380. 被引量:28
  • 5Godinho K S,Keane S G,Nanjiani I A,et al. Minimum Inhibitory Concentrations of Tulathromycin against Respiratory Bacterial Pathogens Isolated from Clinical Cases in European Cattle and Swine and Variability Arising from Chang.es in vitro Methodology [J]. Vet Ther,2005,6(2) :113 -121.
  • 6Reese C P,Norcia L J ,Skogerboe T L,et al. Time - killing Kinetics and Impact of Culture Conditions (pH , CO2 and serum) om MIC Values of Tulathromycin against Hameophilus Sonmus [ D ]. Proc 23rd World Buiatries Congr,2004:70 -71.
  • 7Nowakowski M A,Inskeep P B, Risk J E,et al. Pharmacokinetics and Lung Tissue Concentrations of Tulathromycin, a New Triamilide Antibiotic in Cattle[ J]. Vet Ther,2004, 5 (1) :60 - 74.
  • 8Benchaoui H A, Nowakowski M, Sherington J ,et al. Pharmacokinetics and Lung Tissue Concentrations of Tulathromycin in Swine [J]. Vet Pharmaeol Ther,2004,27(4) :203 -210.
  • 9Eberhard Scheuch A, Janina Spieker A, Monica Venner B, et al. Quantitative Determination of the Macrolide Antibiotic Tulathromycin in Plasma and Broncho - alveolar Cells of Foals Using Tandem Mass Spectrometry [ J].Journal of Chromatography B, 2007,850 : 464 - 470.
  • 10Nutsch R G, Hart F J, Rooney K A,et al. Efficacy of Tulathromycin Injectable Solution for the Treatment of Naturally Occurring Swine Respiratory Disease [ J ]. Vet Ther, 2005,6 ( 2 ) : 214 - 224.

共引文献64

同被引文献85

引证文献8

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部